This study examines the potential of Cannabis sativa L. plants to be repurposed as
therapeutic agents for cancer treatment through designing of hybrid Epidermal growth factor …

Cancer is the world's second leading cause of death, and there are no approved herbal
therapies. The epidermal growth factor receptor tyrosine kinase (EGFR-TK) receptor is a …

Genes related to MAPK-ERK signaling pathways, and epithelial-mesenchymal transition
induction is evolutionarily conserved and has crucial roles in the regulation of important …

Abstract In humans, Epidermal Growth Factor Receptor (EGFR) is linked to small-cell lung
cancer, breast cancer, and glioblastoma. Receptor kinase inhibitors against EGFR have …

Context As a member of a large family of proteins that together regulate various aspects of
cell growth and development, the epidermal growth factor receptor (EGFR) is a validated …

Epigallocatechin gallate (EGCG) is a major polyphenols of green tea may have the
possibility to inhibit epidermal growth factor receptor (EGFR) activity and lead to reduce non …

The emergence of a novel coronavirus that later on rendered a global pandemic, caused
desperation within the communities and drove increased interest in exploring medicinal …

Epidermal growth factor receptor (EGFR) is an important validated drug target for cancer
therapy. Some therapeutic agents targeting EGFR have been developed, however these are …

Background Cancer is one of the leading causes of death worldwide. Recently, it was shown
that many natural extracts have positive effects against cancer, compared with …

Background: The receptor tyrosine kinase of the epidermal growth factor receptor (EGFR,
ErbB) family played an important role in multisignaling pathways, which controlled …